回复：终末期肾病患者使用舒更葡糖钠：现在给予“免死金牌”还为时过早。 - Suppr | 超能文献

In reply: Sugammadex in end-stage renal disease: too early for a "free-pass".

作者信息

Renew J Ross, Porter Steven B, Porter Ivan, Paredes Stephania

机构信息

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Florida, Jacksonville, FL, USA.

Division of Nephrology, Mayo Clinic Florida, Jacksonville, FL, USA.

出版信息

Can J Anaesth. 2021 Feb;68(2):266-267. doi: 10.1007/s12630-020-01861-8. Epub 2020 Nov 18.

DOI:10.1007/s12630-020-01861-8

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

In reply: Sugammadex in end-stage renal disease: too early for a "free-pass".回复：终末期肾病患者使用舒更葡糖钠：现在给予“免死金牌”还为时过早。

Can J Anaesth. 2021 Feb;68(2):266-267. doi: 10.1007/s12630-020-01861-8. Epub 2020 Nov 18.

2

Sugammadex in end-stage renal disease: too early for a "free-pass".舒更葡糖钠用于终末期肾病：现在说“免检”还为时过早。

Can J Anaesth. 2021 Feb;68(2):264-265. doi: 10.1007/s12630-020-01860-9. Epub 2020 Nov 16.

3

Efficacy and Safety of Sugammadex for the Reversal of Rocuronium-Induced Neuromuscular Blockade in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis.罗库溴铵诱导的神经肌肉阻滞在终末期肾病患者中的逆转：舒更葡糖钠的疗效和安全性：系统评价和荟萃分析。

Medicina (Kaunas). 2021 Nov 17;57(11):1259. doi: 10.3390/medicina57111259.

4

Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study.严重至终末期肾衰竭患者罗库溴铵和 sugammadex 清除率降低：一项药代动力学研究。

Br J Anaesth. 2010 Jan;104(1):31-9. doi: 10.1093/bja/aep340.

5

Sugammadex Reversal of a Large Subcutaneous Depot of Rocuronium in a Dialysis Patient: A Case Report.舒更葡糖钠逆转透析患者罗库溴铵的大量皮下储库效应：一例报告

A A Pract. 2019 May 15;12(10):375-377. doi: 10.1213/XAA.0000000000000934.

6

Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.舒更葡糖钠用于终末期肾病患者罗库溴铵所致深度神经肌肉阻滞逆转的有效性和安全性：一项对比性前瞻性临床试验

Eur J Anaesthesiol. 2015 Oct;32(10):681-6. doi: 10.1097/EJA.0000000000000312.

7

Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function.多中心、平行组、对照试验，评估舒更葡糖钠在终末期肾衰竭患者或肾功能正常患者中的疗效和安全性。

Br J Anaesth. 2008 Oct;101(4):492-7. doi: 10.1093/bja/aen216. Epub 2008 Jul 23.

8

Effects of Sugammadex Plus Rocuronium vs Neostigmine Plus Cisatracurium During Renal Transplantation on Graft Function: A Retrospective, Case-Control Study.罗库溴铵联合氨甲酰胆碱与顺苯磺酸阿曲库铵联合新斯的明对肾移植患者移植物功能的影响：一项回顾性病例对照研究。

Transplant Proc. 2021 Apr;53(3):818-824. doi: 10.1016/j.transproceed.2020.09.012. Epub 2020 Oct 15.

9

Short-term safety and effectiveness of sugammadex for surgical patients with end-stage renal disease: a two-centre retrospective study.终末期肾病手术患者应用琥珀酸舒更葡糖钠的短期安全性和有效性：一项两中心回顾性研究。

Anaesthesia. 2020 Mar;75(3):348-352. doi: 10.1111/anae.14914. Epub 2019 Nov 12.

10

Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment.重症肾损伤的重症监护患者中，罗库溴铵及其复合物与 sugammadex 的可透析性。

Br J Anaesth. 2012 Sep;109(3):382-90. doi: 10.1093/bja/aes207. Epub 2012 Jun 24.

引用本文的文献

1

Efficacy and Safety of Sugammadex for the Reversal of Rocuronium-Induced Neuromuscular Blockade in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis.罗库溴铵诱导的神经肌肉阻滞在终末期肾病患者中的逆转：舒更葡糖钠的疗效和安全性：系统评价和荟萃分析。

Medicina (Kaunas). 2021 Nov 17;57(11):1259. doi: 10.3390/medicina57111259.

2

Sugammadex in end-stage renal disease: too early for a "free-pass".舒更葡糖钠用于终末期肾病：现在说“免检”还为时过早。

Can J Anaesth. 2021 Feb;68(2):264-265. doi: 10.1007/s12630-020-01860-9. Epub 2020 Nov 16.